Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Cervical Cancer

Free Subscription 04.05.2026 1 Acta Obstet Gynecol Scand 1 AJPM Focus 1 Am J Prev Med 1 Biol Trace Elem Res 1 Biometrics 1 BMC Public Health 2 BMC Womens Health 1 BMJ Glob Health 1 BMJ Open 1 Brachytherapy 1 Cancer Control 1 Cancer Manag Res 1 Cancer Rep (Hoboken) 1 Cancer Res Commun 1 Curr Oncol 3 Discov Oncol 1 Eur J Surg Oncol 1 Front Endocrinol (Lausanne) 1 Front Immunol 3 Front Oncol 2 Front Public Health 1 Front Surg 1 Gynecol Oncol Rep 1 Health Care Women Int 1 Hum Vaccin Immunother 1 In Silico Pharmacol 1 In Vivo 1 Indian J Surg Oncol 1 Infect Agent Cancer 1 Int J Infect Dis 1 Int J Radiat Oncol Biol Phys 1 Int J Womens Health 1 Integr Cancer Ther 1 J Imaging Inform Med 1 J Infect Dis 1 J Int Med Res 1 J Med Imaging Radiat Oncol 2 J Med Virol 1 J Nanobiotechnology 1 J Natl Compr Canc Netw 1 J Obstet Gynaecol Res 1 J Transl Med 1 JAMA Netw Open 2 JCO Glob Oncol 1 JMIR Cancer 1 Microbiol Spectr 1 Mol Pharm 1 Nucleosides Nucleotides Nucleic Acids 1 Obstet Gynecol 1 Oncol Rep 1 PeerJ 1 Phys Eng Sci Med 3 PLoS One 1 Public Health Nurs 1 Rev Colomb Obstet Ginecol 1 Rofo 1 Rural Remote Health 3 Sci Rep 1 Technol Cancer Res Treat 1 Trop Life Sci Res 1 Vaccine 2 Viruses 1 Womens Health (Lond) 2 Zhonghua Fu Chan Ke Za Zhi 1 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. ALAREF G, Petersen LK
   Accuracy of human papillomavirus testing in detecting persistent or recurrent disease at follow-up after conization.
   Acta Obstet Gynecol Scand. 2026;105:960-968.
   PubMed         Abstract available
   
   

   
   AJPM Focus

2. SLESNICK LD, Gordy E, Class QA, Gokhale P, et al
   Follow-Up Cervical Cancer Screening After Benign and Low-Grade Colposcopy.
   AJPM Focus. 2025;5:100425.
   PubMed         Abstract available
   
   

   
   Am J Prev Med

3. KLEIN KV, Srivastava PV, Sauer JM, Trivedi N, et al
   The Impact of a Student-Led Initiative to Improve Cancer Screenings in Primary Care.
   Am J Prev Med. 2026;70:108262.
   PubMed         Abstract available
   
   

   
   Biol Trace Elem Res

4. TANAKA YK, Yamazaki K, Yomogita N, Yamazaki S, et al
   Evaluation of Platinum Transfer to Breast Milk in Cervical Cancer Patient Undergoing Cisplatin-Based Chemotherapy.
   Biol Trace Elem Res. 2026 Apr 25. doi: 10.1007/s12011-026-05114.
   PubMed        
   
   

   
   Biometrics

5. MAO F, Cook RJ, Lorey T, Wentzensen N, et al
   Two-phase designs for cost-effective evaluation of cancer screening tests.
   Biometrics. 2026;82:ujag058.
   PubMed         Abstract available
   
   

   
   BMC Public Health

6. SK ABD RAZAK R, Amsah N, Heng PP, Jane Ling MY, et al
   Barriers and facilitators of cervical cancer screening among female healthcare professionals: a systematic review.
   BMC Public Health. 2026 Apr 27. doi: 10.1186/s12889-026-27501.
   PubMed        
   
   

   
   BMC Womens Health

7. AN JE, Kim NK, Lee SH, Kim KH, et al
   Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.
   BMC Womens Health. 2026 Apr 27. doi: 10.1186/s12905-026-04459.
   PubMed        
   
   
8. DELATTRE C, Uthuriague M, Barnetche T, Lambert M, et al
   Cervical cancer screening practices among patients with autoimmune and inflammatory rheumatic diseases: a descriptive cross-sectional observational study.
   BMC Womens Health. 2026 Apr 25. doi: 10.1186/s12905-026-04475.
   PubMed        
   
   

   
   BMJ Glob Health

9. KOVALYOV O, Kovalyov K, Deinichenko O, Dillner J, et al
   HPV self-sampling for cervical cancer screening during wartime: a pilot implementation study from a conflict-affected region of Ukraine.
   BMJ Glob Health. 2026;11:e023478.
   PubMed         Abstract available
   
   

   
   BMJ Open

10. ANDREW-BASSEY UI, Bello YO, Okunlola MA, Morhason-Bello IO, et al
    Women's preferences and concerns on HPV screening sampling methods for cervical cancer in Ibadan, Nigeria: a cross-sectional study.
    BMJ Open. 2026;16:e110692.
    PubMed         Abstract available
    
    

    
    Brachytherapy

11. HE L, Liang W, Zheng Y, Wu Q, et al
    A GPU-accelerated brachytherapy planning framework for template-based applications: Evaluated on three-dimensional printed individual templates in cervical cancer.
    Brachytherapy. 2026 Apr 24:S1538-4721(26)00025.
    PubMed         Abstract available
    
    

    
    Cancer Control

12. HERNANDEZ S, Ahuja A, Kakkad N, Nignang CT, et al
    "My Wife's Healthcare Is my Healthcare": A Qualitative Study Exploring Family-Centered Strategies to Enhance Cervical Cancer Prevention in Northern Ghana.
    Cancer Control. 2026;33:10732748261448259.
    PubMed         Abstract available
    
    

    
    Cancer Manag Res

13. MUTYABA I, Akurut H, Nabaasa R, Limo J, et al
    Facilitators and Barriers to Cervical Cancer Screening Among Women in a Rural District of Northeastern Uganda, a Qualitative Study.
    Cancer Manag Res. 2026;18:598738.
    PubMed         Abstract available
    
    

    
    Cancer Rep (Hoboken)

14. MATHIBELA SP, Lebelo MT, Steenkamp V
    Antiproliferative Effects of Cannabinoids and Cisplatin in Cervical Cancer Cells.
    Cancer Rep (Hoboken). 2026;9:e70561.
    PubMed         Abstract available
    
    

    
    Cancer Res Commun

15. WENDEL SO, Brooke GM, Hu C, Sandoval AR, et al
    Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer.
    Cancer Res Commun. 2026 Apr 27. doi: 10.1158/2767-9764.CRC-25-0648.
    PubMed         Abstract available
    
    

    
    Curr Oncol

16. WANG F, Zhan Q, Dai Z, Zhang H, et al
    Lattice Radiation Therapy Plays a Synergistic Role in the Radical Treatment of Bulky Cervical Cancer: A Case Report and Literature Review.
    Curr Oncol. 2026;33:196.
    PubMed         Abstract available
    
    

    
    Discov Oncol

17. SHEN F, Chen J, Gu Y, Li Y, et al
    Cervical cancer derived extracellular vesicles expressed higher level of CD24 and suppressed the phagocytosis of macrophages.
    Discov Oncol. 2026 Apr 29. doi: 10.1007/s12672-026-05124.
    PubMed         Abstract available
    
    
18. MENGISTIE MB, Mengstie SK, Teferi GH, Shume AW, et al
    Predicting cervical cancer among women living with HIV/AIDS at public health facilities in a resource-limited setting in Ethiopia using machine learning analysis.
    Discov Oncol. 2026 Apr 24. doi: 10.1007/s12672-026-05043.
    PubMed        
    
    
19. DIAZ-PALOMERA CD, Gonzalez-Lucano LR, Garcia-Bernal JR, de Arellano-Sanchez JAR, et al
    Modulatory effects of Pioglitazone on the CAF-driven malignant phenotype in cervical cancer: an in vitro bidirectional study.
    Discov Oncol. 2026 Apr 25. doi: 10.1007/s12672-026-04898.
    PubMed        
    
    

    
    Eur J Surg Oncol

20. WEI T, Li Y, Zhang Z, Xu Y, et al
    Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021.
    Eur J Surg Oncol. 2026;52:111742.
    PubMed         Abstract available
    
    

    
    Front Endocrinol (Lausanne)

21. JIANG Y, Cui Y, Su D, Yang H, et al
    Immune checkpoint inhibitor-associated diabetic ketoacidosis induced by cadonilimab: a case report and literature review.
    Front Endocrinol (Lausanne). 2026;17:1819809.
    PubMed         Abstract available
    
    

    
    Front Immunol

22. XU Z, Zhang L, Wang H, Li X, et al
    Combined neutrophil-to-lymphocyte ratio and nomogram for predicting progression-free survival in recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors.
    Front Immunol. 2026;17:1811428.
    PubMed         Abstract available
    
    

    
    Front Oncol

23. WANG Y, Tang N, Zhang W, Zeng Y, et al
    An interpretable machine learning model for predicting symptomatic pelvic lymphocele after pelvic lymphadenectomy in cervical cancer.
    Front Oncol. 2026;16:1754363.
    PubMed         Abstract available
    
    
24. DERIBE KS, Shewaye S, Wondimagegnehu A, Azmera YM, et al
    Unmet palliative care needs and determinants among women with breast and cervical cancer and their caregivers in Ethiopia.
    Front Oncol. 2026;16:1788481.
    PubMed         Abstract available
    
    
25. WANG S, Xiao H, Gao H
    A novel methylation marker on the CLEC14A gene for cervical cancer screening.
    Front Oncol. 2026;16:1730952.
    PubMed         Abstract available
    
    

    
    Front Public Health

26. NEMETH BLAZIC T, Zhu Q, Cahun E, Nola IA, et al
    Developing a digital interactive tool to enhance cervical cancer awareness and health literacy in Croatia: a community case study.
    Front Public Health. 2026;14:1767197.
    PubMed         Abstract available
    
    
27. DING N, Chen Y, Zhou X, Wang G, et al
    Women's preferences for HPV self-sampling in cervical cancer screening: a discrete choice experiment.
    Front Public Health. 2026;14:1779443.
    PubMed         Abstract available
    
    

    
    Front Surg

28. SHU H, Wang M, Zhang L, Jiang X, et al
    Application of omental flap in total vaginectomy for post-radiotherapy recurrent cervical cancer: a case report.
    Front Surg. 2026;13:1779661.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

29. BADWAN SN, McKinnish TR, Massad LS, Markovina S, et al
    Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer.
    Gynecol Oncol Rep. 2026;65:102083.
    PubMed         Abstract available
    
    

    
    Health Care Women Int

30. GORGATI E, Lotfi F, Boughriou M, Zendehdel K, et al
    Cervical cancer prevention in migrant women: Overcoming barriers.
    Health Care Women Int. 2026 Apr 28:1-7. doi: 10.1080/07399332.2026.2660648.
    PubMed        
    
    

    
    Hum Vaccin Immunother

31. PRUSKI D, Millert-Kalinska S, Zurawski J, Jach R, et al
    The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients.
    Hum Vaccin Immunother. 2026;22:2664310.
    PubMed         Abstract available
    
    

    
    In Silico Pharmacol

32. KAWIA H, Mgaya J, Paul L
    Linamarin and its analogues as targeted therapeutic agents in cervical cancer: insights from atomistic molecular docking, dynamics and MMPBSA calculations.
    In Silico Pharmacol. 2026;14:132.
    PubMed         Abstract available
    
    

    
    In Vivo

33. GARCIA-MONTOYA IA, Picazo-Perez L, Arellano-Ortiz AL, Salcedo-Vargas M, et al
    Obesity and Pro-Inflammatory Cytokines: Gene Expression Patterns Within Cervical Cancer Progression.
    In Vivo. 2026;40:1463-1472.
    PubMed         Abstract available
    
    

    
    Indian J Surg Oncol

34. HULIKAL N, Panneerselvam V, Banoth M, Singaram NK, et al
    Open Versus Laparoscopic Radical Hysterectomy Using Myoma Screw for Early-Stage Cervical Cancer- A Retrospective Analysis from Pre-LACC Era.
    Indian J Surg Oncol. 2026;17:670-675.
    PubMed         Abstract available
    
    

    
    Infect Agent Cancer

35. TAO H, Tong Z, Li H, Mao S, et al
    Paired box 1 gene methylation as a promising triage strategy for atypical squamous cells: a retrospective comparison with high-risk HPV testing in cervical cancer screening.
    Infect Agent Cancer. 2026 Apr 24. doi: 10.1186/s13027-026-00763.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

36. TAGUE C, Junaid A, Anwar Y, Asad S, et al
    Human papillomavirus: role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa.
    Int J Infect Dis. 2026 Apr 25:108733. doi: 10.1016/j.ijid.2026.108733.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

37. SAINI SK, Srivastava S, Goel A, Sharma DN, et al
    Outcomes of Stage IVA Cervical Cancer Treated with Radiotherapy: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2026 Apr 23:S0360-3016(26)00571.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

38. PHISALMONHKHON T, Kantathavorn N, Wetcho T, Samrarn J, et al
    Long-Term Survival Outcomes of HPV DNA-Negative Cervical Cancer Compared with HPV DNA-Positive Disease in a Thai Tertiary Cohort.
    Int J Womens Health. 2026;18:601452.
    PubMed         Abstract available
    
    

    
    Integr Cancer Ther

39. LEE CY, Wang PH, Hsieh YH, Hsiao YH, et al
    GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling.
    Integr Cancer Ther. 2026;25:15347354251411859.
    PubMed         Abstract available
    
    

    
    J Imaging Inform Med

40. WANG M, Zuo C, Wang K, Li F, et al
    BA-UNet: A Boundary Augmented Segmentation Network for Cervical Cancer Radiotherapy.
    J Imaging Inform Med. 2026 Apr 28. doi: 10.1007/s10278-026-01953.
    PubMed         Abstract available
    
    

    
    J Infect Dis

41. RYSER MD, Bravo IG, Campos NG, Hammer A, et al
    IPVS Consensus Statement on the Natural History of Cervical HPV Infection.
    J Infect Dis. 2025 Nov 14:jiaf574. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Int Med Res

42. ZHANG Y, Zhuo Q, Abuduwufu S, Wushouer A, et al
    Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways.
    J Int Med Res. 2026;54:3000605261441200.
    PubMed         Abstract available
    
    

    
    J Med Imaging Radiat Oncol

43. FRANKLIN G, Larsen P, Henry C, Johnson C, et al
    Financial Toxicity in Cervical Cancer Patients Undergoing Radical Treatment With External Beam Radiation and Brachytherapy at a Tertiary New Zealand Radiation Oncology Centre.
    J Med Imaging Radiat Oncol. 2026 Apr 28. doi: 10.1111/1754-9485.70112.
    PubMed         Abstract available
    
    

    
    J Med Virol

44. YILMAZ E, Murray GL, Balgovind P, Garland SM, et al
    International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.
    J Med Virol. 2026;98:e70936.
    PubMed         Abstract available
    
    
45. YANG Y, Zhou H, Wang Y, Zhang H, et al
    A Triage Model for HR-HPV Positive Women Based on Methylation of Human and HPV Genes.
    J Med Virol. 2026;98:e70930.
    PubMed         Abstract available
    
    

    
    J Nanobiotechnology

46. JIANG CQ, Song Z, Yan ZC, Liu Y, et al
    MXene-based CRISPR/Cas9 nanoplatform targeting FABP5 for ROS amplification and synergistic photothermal/photodynamic therapy of cervical cancer.
    J Nanobiotechnology. 2026 Apr 27. doi: 10.1186/s12951-026-04480.
    PubMed         Abstract available
    
    

    
    J Natl Compr Canc Netw

47. CALDERON AM, Goyal S, Peddinani B, Lopez M, et al
    EPR26-154: Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data.
    J Natl Compr Canc Netw. 2026;24.
    PubMed        
    
    

    
    J Obstet Gynaecol Res

48. KOKSAL OK, Baydemir SK, Oncu HN, Bakan FE, et al
    The Association Between the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score and Lymph Node Metastasis in Early and Locally Advanced Cervical Cancer.
    J Obstet Gynaecol Res. 2026;52:e70290.
    PubMed         Abstract available
    
    

    
    J Transl Med

49. WANG D, Wu S, Wang H, Yan B, et al
    FAT4 restrains epithelial-mesenchymal transition and metastasis in cervical cancer and shapes the tumor immune microenvironment.
    J Transl Med. 2026 Apr 28. doi: 10.1186/s12967-026-08177.
    PubMed        
    
    

    
    JAMA Netw Open

50. ORTIZ AP, Ramos-Cartagena JM, Torres-Cintron CR, Santiago-Rodriguez EJ, et al
    Age Differences in Hysterectomy-Corrected Cervical Cancer Incidence Trends in Puerto Rico, 2001-2023.
    JAMA Netw Open. 2026;9:e269681.
    PubMed        
    
    

    
    JCO Glob Oncol

51. BONI S, Goore D, Adie M, Gnahatin F, et al
    Cervical Cancer Screening Cascade in Cote d'Ivoire: A Decade of Real-World Program Evaluation According to HIV Status.
    JCO Glob Oncol. 2026;12:e2500164.
    PubMed         Abstract available
    
    
52. GUPTA RD, Sarker P, Haider SS, Mazumder A, et al
    Determinants and Socioeconomic Inequalities in Breast and Cervical Cancer Screening in Tajikistan: Evidence From the 2023 Demographic and Health Survey.
    JCO Glob Oncol. 2026;12:e2500582.
    PubMed         Abstract available
    
    

    
    JMIR Cancer

53. SATOH M, Sato N
    Participation in Cervical and Breast Cancer Screening Among Working Women in Japan: Panel Survey Study.
    JMIR Cancer. 2026;12:e86885.
    PubMed         Abstract available
    
    

    
    Microbiol Spectr

54. ZHANG T, Yu Y, Zhang C, Zhang M, et al
    Multi-omics analysis reveals the alterations in the tumor microbiome and metabolome associated with cervical cancer lymph node metastasis.
    Microbiol Spectr. 2026 Apr 30:e0224725. doi: 10.1128/spectrum.02247.
    PubMed         Abstract available
    
    

    
    Mol Pharm

55. YANG N, Liu L, Ding L, Chen Z, et al
    GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation.
    Mol Pharm. 2026 Apr 27. doi: 10.1021/acs.molpharmaceut.6c00002.
    PubMed         Abstract available
    
    

    
    Nucleosides Nucleotides Nucleic Acids

56. YAN Y, Li J, Zhang C, Yang R, et al
    miR-1247-5p is correlated with cervical cancer and regulates cervical cancer cell functions by targeting DVL1.
    Nucleosides Nucleotides Nucleic Acids. 2026.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

57. CLARK M, Rusley J, Graham C, Cronin B, et al
    Self-Sampling for Cervical Cancer Screening in Transmasculine and Nonbinary People.
    Obstet Gynecol. 2026 Apr 30. doi: 10.1097/AOG.0000000000006296.
    PubMed         Abstract available
    
    

    
    Oncol Rep

58. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
    [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
    Oncol Rep. 2026;55:120.
    PubMed         Abstract available
    
    

    
    PeerJ

59. LU S, Liu K, Luo W, Zheng S, et al
    PD-L1 expression patterns in stage IB1 cervical squamous cell carcinoma: a retrospective study on implications for tumor budding and immune microenvironment.
    PeerJ. 2026;14:e21052.
    PubMed         Abstract available
    
    

    
    Phys Eng Sci Med

60. HUANG M, Gong C, Liu B, Wang Y, et al
    Exploration of overlap volumes-based IMRT Rapidplan for cervical cancer patients with the aim of OARs sparing.
    Phys Eng Sci Med. 2026 Apr 29. doi: 10.1007/s13246-026-01732.
    PubMed        
    
    

    
    PLoS One

61. BITEWA MD, Yewodiaw TK, Abneh AA, Molla MG, et al
    Determinants of cervical cancer screening among women aged 30 to 49 years in 20 low- and middle-income countries: A multilevel analysis.
    PLoS One. 2026;21:e0347837.
    PubMed         Abstract available
    
    
62. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
    Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey.
    PLoS One. 2026;21:e0348076.
    PubMed         Abstract available
    
    
63. TILAHUN SW, Nega A, Wagaw L, Addissie A, et al
    Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2026;21:e0348172.
    PubMed         Abstract available
    
    

    
    Public Health Nurs

64. AJROUDI OE, Razzok EM, Khadija Z, Safae H, et al
    Adherence to Human Papillomavirus Vaccination in the Province of Oujda-Angad, Morocco.
    Public Health Nurs. 2026;43:595-605.
    PubMed         Abstract available
    
    

    
    Rev Colomb Obstet Ginecol

65. ALVAREZ A, Diaz S, Nino RA, Medina YA, et al
    Cost-effectiveness of Including p16/Ki-67 Dual Staining in the Detection of Cervical Lesions in Colombia, 2024.
    Rev Colomb Obstet Ginecol. 2026;77.
    PubMed         Abstract available
    
    

    
    Rofo

66. GIGI AL, Vanslembrouck R, Bonne L, Timmerman D, et al
    Technical results and clinical outcome of transcatheter embolization for severe post-hysterectomy intra-abdominal hemorrhage.
    Rofo. 2026;198:635-643.
    PubMed         Abstract available
    
    

    
    Rural Remote Health

67. AGU PU, Dim CC, Nnagbo JE, Odoh GU, et al
    Awareness of cervical cancer prevention among rural dwellers in Enugu State, Nigeria: findings from Ituku outreach.
    Rural Remote Health. 2026;26:10083.
    PubMed         Abstract available
    
    

    
    Sci Rep

68. BAHRA N, Chami Y, Bekkali R, Bennani M, et al
    Feasibility and acceptability of HPV testing using GeneXpert for cervical cancer screening in Morocco.
    Sci Rep. 2026 Apr 24. doi: 10.1038/s41598-026-46200.
    PubMed        
    
    
69. ZHU Q, Xu G, Wang T, Ding Z, et al
    Downregulation of LRRC59 suppresses cervical cancer progression likely by inhibiting YBX1-mediated Wnt/beta-catenin signaling.
    Sci Rep. 2026 Apr 28. doi: 10.1038/s41598-026-50275.
    PubMed         Abstract available
    
    
70. CHO AR, Park SY, Sim DY, Ahn CH, et al
    Targeting the CNOT2/VEGF pathway by Cornin attenuates angiogenesis and invasion in cervical cancer cells.
    Sci Rep. 2026 Apr 27. doi: 10.1038/s41598-026-50829.
    PubMed         Abstract available
    
    

    
    Technol Cancer Res Treat

71. LU L, Chen X, Liu J, Chen G, et al
    A Lightweight Skeletal Muscle Intelligent Segmentation Network Based on Planning CT for Cervical Cancer Radiotherapy.
    Technol Cancer Res Treat. 2026;25:15330338261446535.
    PubMed         Abstract available
    
    

    
    Trop Life Sci Res

72. ABDULLAH H, Mamat N, Sazeli S, Hapidin H, et al
    Upregulation of Apoptotic Protein and Migration-Inhibitory Effects of Gallic Acid and Methyl Gallate Combined with Cisplatin in HeLa Cervical Cancer Cells.
    Trop Life Sci Res. 2026;37:109-131.
    PubMed         Abstract available
    
    

    
    Vaccine

73. MENICAGLI D, Casigliani V, Panizza F, Gandolfi S, et al
    HPVoice: a single-blind three-arm RCT on social media communication strategies among adolescents in Tuscany, Italy.
    Vaccine. 2026;79:128466.
    PubMed         Abstract available
    
    

    
    Viruses

74. KNAP-WIELGUS W, Knap A, Pietrzak B, Suchonska B, et al
    A Role of the Lower Genital Tract Microbiome in Promoting Cervical Intraepithelial Neoplasia: A Premalignant Precursor of Cervical Cancer-A Literature Review.
    Viruses. 2026;18:403.
    PubMed         Abstract available
    
    
75. GUNGOR SERIN B, Temiz BE, Tuncer H, Atakul MO, et al
    Association of Oral Papivir/Pavirona((R)) Supplementation with HPV DNA Clearance.
    Viruses. 2026;18:455.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

76. ATAYA J, Alotaki B, Alhammadi K, Homsi TA, et al
    Knowledge, attitudes, and practices regarding cervical cancer screening among women in Damascus, Syria: A cross-sectional study.
    Womens Health (Lond). 2026;22:17455057261443140.
    PubMed         Abstract available
    
    

    
    Zhonghua Fu Chan Ke Za Zhi

77. DENG ZP, Wu D, Lai WX, Geng LN, et al
    [Evaluating the efficiency of 24 secondary triage strategies for detecting cervical lesions of self-collected high-risk HPV-positive women].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:289-304.
    PubMed         Abstract available
    
    
78. WU SY, Wang DY, He JX, Wang HX, et al
    [Experimental study on the inhibitory effects of recombinant bee venom peptide on the malignant biological behavior of cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:316-327.
    PubMed         Abstract available
    
    

    
    Zhonghua Yi Xue Za Zhi

79. ZHAO ZY, Zheng QJ, Zhao XL, Zhao FH, et al
    [Current status of artificial intelligence applications in cervical cancer screening: a systematic review].
    Zhonghua Yi Xue Za Zhi. 2026;106:1630-1638.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum